After decades of overtreatment for low-risk prostate cancer and inadequate management of its more aggressive forms, patients are now more likely to receive medical care matched to level of risk, ...

New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.

Prostate cancer is the second-leading cause of cancer death in American men. About 1 in 8 men will be diagnosed with prostate ...

Researchers say they've developed a urine test that could answer whether prostate cancer is aggressive and requiring immediate treatment, or slow-growing and worthy ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

Higher serum creatinine levels that are still within normal ranges are associated with a significantly increased risk of prostate cancer, according to a new study. Compared with patients in the lowest ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its Decipher Prostate Genomic Classifier is the only gene ...

Investigators evaluated the benefit of leuprorelin immediately after radical prostatectomy for prostate cancer in patients ...

NEW YORK (Reuters Health) - The results of a study published in the International Journal of Cancer indicate there is an association between dietary calcium and the risk of prostate cancer. It has ...

When prostate cancer strikes, one question is paramount: Is it aggressive and requiring immediate treatment, or slow-growing and worthy of monitoring only? Right now, an invasive biopsy is the only ...